GLOW Peptide (BPC-157 + TB-500 + GHK-Cu): High-Purity Laboratory Research Blend
Product Specifications
CAS #: N/A (Custom peptide blend)
Formula: Proprietary combination of BPC-157, TB-500, and GHK-Cu
Molecular Weight: Variable (blend dependent)
Purity: ≥99% (HPLC Verified)
Listed 70 mg presentation: 50 mg GHK-Cu, 10 mg TB-500, and 10 mg BPC-157 in a 3 mL vial.
For laboratory research use only. Not for use in humans or animals.
Product Description
GLOW Peptide combines BPC-157, TB-500, and GHK-Cu for laboratory investigation of cell signaling, cell migration, and extracellular-matrix markers. Its three-component composition provides a material for examining multiple biochemical endpoints within controlled assay systems.
BPC-157 provides research context for cell-signaling and angiogenesis-related measurements. TB-500 is associated with cytoskeletal organization and cell-motility research. GHK-Cu, a copper-binding tripeptide, provides context for collagen-synthesis, oxidative-stress, and extracellular-matrix measurements. These component-level contexts do not establish a particular response to the supplied blend.
Laboratory studies may examine cell proliferation, migration-related readouts, and inflammation-pathway markers using appropriate controls. Interpretation depends on the experimental model, concentrations, material composition, and assay conditions. The presence of three components does not establish additive or synergistic effects.
The listed purity is ≥99%, HPLC verified. Batch analytical documentation provides the relevant quality-control information for evaluating the material within molecular and cellular assays. Purity alone does not guarantee experimental reproducibility or solution stability.
Store at −20°C and limit repeated freezing and thawing. The existing handling recommendation specifies a 30-day laboratory-use window after solubilization; assess compatibility and stability in the selected solvent system under the specific assay conditions.
For laboratory research use only. Not for use in humans or animals.
Features / Highlights of GLOW Peptide
- Three-component peptide blend for cell-signaling and extracellular-matrix assays
- Listed purity of ≥99%, HPLC verified
- BPC-157, TB-500, and GHK-Cu component research context
- Cell migration, collagen-related readouts, and inflammation-pathway markers
- Batch documentation for laboratory material assessment
Research Literature Context
The existing bibliography lists Sikiric P. (2018), Curr Pharm Des., for BPC-157 research; Pickart L. (2015), J Biomater Sci Polym Ed., for GHK-Cu research; and Malinda KM. (1999), J Invest Dermatol., for thymosin β4 and cell-migration research. Component-level literature provides assay context and does not establish properties of the supplied blend. Thymosin β4 literature should be interpreted according to the molecular identity described in each paper.
Research Endpoints
The research topics listed for the components include nitric-oxide signaling, angiogenesis-related measurements, collagen synthesis, and extracellular-matrix markers. Evaluate each endpoint within the defined laboratory model and interpret results alongside controls and material characterization.
Storage Instructions
- Store at −20°C
- Limit repeated freezing and thawing
- The existing handling recommendation specifies laboratory use within 30 days after solubilization; evaluate stability in the selected solvent system
FAQs
What is the intended use of GLOW Peptide?
GLOW Peptide is supplied for laboratory research and analytical characterization. For laboratory research use only. Not for use in humans or animals.
What is the listed purity of this peptide blend?
The listed purity is ≥99%, HPLC verified. Review the batch analytical documentation when assessing the material for a specific assay.
What are the main research applications?
Laboratory research contexts include cell signaling, cell migration, cytoskeletal organization, collagen-matrix readouts, and inflammation-pathway markers in controlled assay systems.
Which components are included in GLOW Peptide?
The blend contains BPC-157, TB-500, and GHK-Cu. The listed 70 mg presentation contains 10 mg BPC-157, 10 mg TB-500, and 50 mg GHK-Cu in a 3 mL vial. Component-level research does not establish combined effects for the blend.
References
Existing bibliography identifiers: PubMed PMID 29589705; PMID 25744421; PMID 10469337. Consult the original records for the compounds, models, and analytical endpoints studied.
For laboratory research use only. Not for use in humans or animals.
